Show lung deposition of triple drug combination in Inhalation Suspension: CDSCO Panel tells Glenmark on Pulmonary FDC Drug Dr. Divya Colin2 Nov 2023 5:37 PM ISTNew Delhi: In line with the proposal presented by the drug major Glenmark Pharmaceuticals for the bioequivalence (BE) and Phase III clinical trial...
Zydus Healthcare Gets CDSCO Panel Nod To Market Vilanterol, Glycopyrrolate, Fluticasone Metered Dose Inhaler Dr. Divya Colin13 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Approves AstraZeneca's Phase III CT proposal For COPD Drug Tozorakimab Dr. Divya Colin19 Aug 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Gets CDSCO Panel Nod To study COPD Drug Tozorakimab Dr. Divya Colin25 May 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Glenmark Gets CDSCO panel nod for Phase IV CT of COPD drug Dr. Divya Colin22 April 2023 5:45 PM ISTNew Delhi: Pharmaceutical major, Glenmark has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma gets CDSCO panel nod to study COPD drug combination Dr. Divya Colin6 April 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Rationale to conduct trial of Tozorakimab is not adequate: CDSCO tells AstraZeneca Dr. Divya Colin11 Dec 2022 6:00 PM ISTNew Delhi: Citing that the rationale for conduct of the proposed trial of COPD (Chronic obstructive pulmonary disease) drug Tozorakimab is not...
Cipla gets CDSCO Panel nod to manufacture, market COPD drug combination Aerosol for inhalation Susmita Roy23 Nov 2022 6:00 PM ISTNew Delhi: Granting the phase III clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
